• Title/Summary/Keyword: CJ

Search Result 666, Processing Time 0.026 seconds

Effectiveness of Logistics information Systems for RFID - Focusing on CJ GLS Co. Case - (RFID를 이용한 물류정보시스템의 구축효과 -CJ GLS 사례를 중심으로-)

  • Kim, Moon-jung
    • Journal of Distribution Science
    • /
    • v.5 no.2
    • /
    • pp.79-100
    • /
    • 2007
  • CJ GLS Co. builds successfully Warehouse Management Systme (WMS), Customer Service & Support System(CSS), and Delivery Management System using RFID. This study tris to find out the effectiveness in CJ case. RFID, the core technology of Ubiquitous network, is now implied in our policy by the Ministry of Commerce, Industry & Energy. To support the study, examples from Korea and other countries using RFID system were introduced. Examples include the definition and features of RFID and the current applications of RFID. CJ GLS Co. used RFID to build the Integrated Logistics Management System effectively. The study analyzed the background of why to use this system, the goals and objectives of system building and the effectiveness of system building. In conclusion, the future of RFID and SCM was presented.

  • PDF

Pharmacokinetics of CJ-50001i Recombinant Human Granulocyte-Colony Stimulating Factor, in Rats and Dogs (CJ-50001 (recombinant human granulocyte-colony stimulating factor)의 흰쥐와 개에서의 약물동태학적 연구)

  • 김성남;신재규;이수정;정용환;하석훈;김기완;고형곤;김제학
    • Biomolecules & Therapeutics
    • /
    • v.6 no.4
    • /
    • pp.400-405
    • /
    • 1998
  • The pharmacokinetics of CJ-50001 (recombinant human granulocyte-colony stimulating factor, developed by R&D center of Cheil Jedang Corp.) were investigated in rats and dogs. The serum concentrations of CJ-50001 were measured by a sandwich enzyme immunoassay. After single intravenous (iv) administration of Cf-50001 to rats at a dose of 5 $\mu$g/kg, the mean terminal half-life and area under the concentration-time curve (AUC) were 0.96 h and 124.497g . h/ml, respectively. After single subcutaneous (sc) administration at the same dose, maximum serum concentration was observed at about 2 hours after administration, and the mean terminal half-life, AUC and the bioavailability were 1.11 h,63.58$\mu$g . h/ml and 51.07%, respectively. In repeated dosing studies, CJ-50001 was administered iv and sc to rats at a daily dose of 5$\mu$g/kg for 7 days. The pharmacokinetic parameters, such as mean AUC and terminal half-life, were no significantly different from those of single administration. Following single iv and sc administration of CJ-50001 to dogs at a dose of 5 $\mu$g/kg, mean AUCs were much higher than those of rats, due to the decreased clearence (CL). After sc administration to dogs, maximum serum concentration was observed at 2~4 hours after administration and the bioavailability was 54.60%.

  • PDF

Single Dose Toxicity Studies of C.1-50005 (Hepatitis A virus Vaccine) in Rats and Dogs (CJ-50005(A형 간염백신)의 Rat 및 Dog에서의 단회투여독성)

  • 김종호;이성학;최재목;김달현;김현석;정용주
    • Toxicological Research
    • /
    • v.17 no.4
    • /
    • pp.297-301
    • /
    • 2001
  • The acute toxicity of CJ-50005, an inactivated whole virus vaccine derived from hepatitis A virus (HM175) grown in human MRC-5 diploid fibroblast culture, was tested in Sprague Dawley (SD) rats and beagle dogs. CJ-50005 was orally and intramuscularly administered up to the maximum dose of 81$\mu\textrm{g}$/kg. as much as 3,000 times of the expected clinical dose, in SD rats and was intramuscularly administered up to 27 $\mu\textrm{g}$/kg, as much as 1,000 times of the expected clinical dose, in beagle dogs. In these experiments, there were no death and clinical changes which were related to CJ-50005 administration. In addition, there were no significant changes between control and treated groups in body weights and autopsy findings. In conclusion, the administration of CJ-50005 over 81$\mu\textrm{g}$/kg in SD rats and over 27$\mu\textrm{g}$/kg in beagle dogs was proved to be safe, and it is thought that CJ-50005 may not show any toxicity in its clinical use.

  • PDF

인터뷰 - 윤철주 CJ대한통운 미래기술담당 경영리더

  • (사)한국포장협회
    • The monthly packaging world
    • /
    • s.354
    • /
    • pp.102-105
    • /
    • 2022
  • 최근 CJ대한통운이 박스 측면에 라벨 부착 대신 먹물분사형 바코드를 사용함으로써 친환경 효과를 높이고 있다. 이와 함께 첨단화·자동화를 기반으로 한 다양한 친환경 포장 방식을 적용하면서 물류업계에 수준 높은 'ESG 패키징' 프로세스를 구축하고 있다. CJ대한통운은 배송박스에 먹물분사형 바코드를 사용해 지난 3년간 3천 5백만장의 코팅라벨을 없앴다고 밝혔다. 실제 먹물은 아니지만 오징어가 먹물을 뿜듯이 잉크를 분사한다고 하여 물류현장에서는 '오징어먹물 바코드'라는 별칭으로 불린다. 본지에서는 CJ대한통운의 윤철주 미래기술담당 경영리더와의 서면 인터뷰를 통해 먹물분사형 바코드 표기, 주문별 최적 박스 투입, 종이 포장부자재 사용 등 'ESG 패키징' 확대를 위해 노력하고 있는 그들의 이야기를 들어보았다.

  • PDF

Efficacy of Antagonistic Bacteria for Biological Control of Rhizoctonia Blight (Large patch) on Zoysiagrass (잔디 갈색퍼짐병(Large patch)의 생물학적 방제를 위한 길항 미생물의 선발과 효력 검정)

  • Jung, Woo-Chul;Shin, Taek-Su;Kim, Bong-Su;Im, Jae-Seong;Lee, Jae-Ho;Kim, Jin-Won
    • Research in Plant Disease
    • /
    • v.14 no.1
    • /
    • pp.43-50
    • /
    • 2008
  • Rhizoctonia blight (large patch) caused by Rhizoctonia solani AG2-2 is one of the major diseases on zoysiagrass in golf courses. In this study, anatgonistic bacteria to R. solani AG2-2 were selected in vitro tests using confrontation bioassay and triple layer agar diffusion method. The most active bacteria, Bacillus subtilis CJ-9 were tested for controlling large patch in pots. Relative Performance Indies (RPI) was used as a criterion for the selection of potential biocontrol agent. B. subtilis CJ-9 showed resistance to major synthetic agrochemicals used in golf course. In field tests at golf course, B. subtilis CJ-9 was more effective in suppression of large patch severity and population development of R. solani AG2-2 in soil than chemical fungicides. B. subtilis CJ-9 could be an alternative to chemical fungicides for eco-friendly management of large patch on zoysiagrass.

Effects of Herbal Medicine-added Cheonggugjang extract on Improvement of the Symptoms in Streptozotocin-induced Diabetic Rats (Streptozotocin으로 유발된 흰쥐의 당뇨 증상 개선에 미치는 한약재 첨가 청국장 추출물의 영향)

  • Jo, Chang Suk;Kim, So Young;Choi, Moon-Yeol;Kim, Mi Hyung;Ko, Kyung A;Kim, Mi Ryeo;Seo, Bu-il
    • The Korea Journal of Herbology
    • /
    • v.37 no.4
    • /
    • pp.49-57
    • /
    • 2022
  • Objective : This study was conducted to investigate antidiabetic effects of chunggugjang with medicinal herbal complex (CJ) in streptozotocin (STZ)-induced animal models. Method : STZ (65 mg/kg) was injected intraperitoneally to induce diabetes. Then rats were divided into 5 groups ; NG (normal diet + 0.9% saline), COS (STZ +saline 5 mL/kg), COB (STZ + fermented soybean(100 mg/kg), CJ 100/200 (STZ+CJ(100 and 200 mg/kg), CJ 300/600 (STZ+CJ(300 and 600 mg/kg). 4 weeks later, oral glucose tolerance test (OGTT) was performed. After sacrificing rats, serum levels of blood urea nitrogen (BUN), creatinine, aspartate amino transferase (AST), alanine amino transferase (ALT), total cholesterol (TC), and triglyceride (TG) were measured and histological changes were observed. Result : Body weight change and food efficiency ratio (FER) were decreased in the CJ 300/600 group than in the COS group. But, there was no change in water intake. Serum levels of glucose, AST, ALT and BUN were lower in the CJ 300/600 group than in the COS group. Also, TG, TC, and creatinine were decreased in the CJ 300/600 group than in the COS group. According to OGTT, 120 minutes postprandial glucose levels were lower in the CJ 300/600 group than in the COS group. In addition, administration of CJ extracts restored histopathological damage. Conclusion : The results suggest that CJ can be used as a functional material for diabetes treatment as it has the effect to improve pathological symptoms in STZ-induced diabetic rats.

Evaluation of the Probiotic Potential of Bacillus polyfermenticus CJ6 Isolated from Meju, a Korean Soybean Fermentation Starter

  • Jung, Ji Hye;Lee, Myung Yul;Chang, Hae Choon
    • Journal of Microbiology and Biotechnology
    • /
    • v.22 no.11
    • /
    • pp.1510-1517
    • /
    • 2012
  • To evaluate the probiotic potential of Bacillus polyfermenticus CJ6 isolated from meju, a Korean traditional soybean fermentation starter, its functionality and safety were investigated. B. polyfermenticus CJ6 was sensitive to all antibiotics listed by the European Food Safety Authority. The strain was also non-hemolytic, carried no emetic toxin or enterotoxin genes, and produced no enterotoxins. The resistance of B. polyfermenticus CJ6 vegetative cells and spores to simulated gastrointestinal conditions was high (60-100% survival rate). B. polyfermenticus CJ6 produced high amounts (0.36 g as a purified lyophilized form) of ${\gamma}$-polyglutamic acid (PGA). We speculate that the improved cell viability and the production of ${\gamma}$-PGA have a significant correlation. Adhesion of the strain to Caco-2 and HT-29 cells was weaker than that of the reference strain (Lb. rhamnosus GG), but it was comparable to or stronger than those of reported Bacillus spp. When B. polyfermenticus CJ6 spores were given orally to mice, the number of cells excreted in the feces was 4-fold higher than the original inocula. This suggests the inoculated spores propagated within the intestinal tract of the mice. This idea was confirmed by field emission scanning electron microscopy, which revealed directly that B. polyfermenticus CJ6 cells germinated and adhered within the gastrointestinal tract of mice. Taken together, these findings suggest that B. polyfermenticus CJ6 has probiotic potential for both human consumption and use in animal feeds.

EFFECTS OF ISOTHIAZOLE AND ISOXAZOLE DERIVATIVES AS SELECTIVE CYCLOOXYGENASE-2 INHIBITORS

  • Ryu, Hyung-Chul;Park, Sang-Wook;Noh, Ji-Young;Kim, Jong-Hoon;Park, Hyun-Jung;Chung, Young-Mee;Chae, Myeong-Yun;Cho, Il-Hwan
    • Proceedings of the PSK Conference
    • /
    • 2002.10a
    • /
    • pp.355.3-356
    • /
    • 2002
  • Prostaglandins are synthesized by the enzyme cyclooxygenase (COX). Both constitutive (COX-1) and inducible (COX-2) isoforms have been identified. COX-2 expression is stimulated by inflammatory mediators such as growth factors and cytokines. Most non-steroidal anti-inflammatory drugs (NSAIDS) inhibit both isoforms of COX. Recent evidence suggests that selective inhibitors of COX-2 may possess diminished side effects reletive to common NSAIDS. Novel isothiazoles and isoxazoles were identified as selective inhibitiors of cycloxygenase-2(COX-2). (omitted)

  • PDF